Atlas Trials

Predicting Non-small Cell Lung Cancer (NSCLC) Lymph Node Metastasis: Integrating Circulating Tumor DNA (ctDNA) Mutation/ Methylation Profiling With Positron Emission Tomography-computed Tomography (PET-CT) Scan

Clinical trial NCT06358222 · RECRUITING

Trial details

NCT number
NCT06358222
Sponsor
Shanghai Chest Hospital
Status
RECRUITING
Study type
OBSERVATIONAL
CarcinomaNon-small Cell Lung Cancer
Start date
2023-12-15
Primary completion
2027-12-31
Enrollment
200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.